You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
A number of diagnostic labs have considered saliva-based SARS-CoV-2 testing but decided against it, while other groups continue to pursue it.
A UK town is studying whether it can test its residents for COVID-19 each week, according to New Scientist.
In Science this week: mass spectrometric analysis of the SARS-CoV-2 spike protein, and more.
The researchers hope the datasets from their study can help to explain the effects of disease-associated variants on specific cell types of the immune system.
A Lancet Oncology study finds that young BRCA-positive breast cancer patients have similar survival rates as non-carrier patients, the BBC reports.
Four SNPs at three sites in the genome showed potential associations with breast cancer outcomes in a GWAS meta-analysis involving more than 6,000 individuals.
While point-of-care molecular testing of patients with respiratory illness wasn't associated with lower antibiotic use, patients tested had shorter drug courses.
The method offers a way for genome-wide arrays to be used in individual patients to uncover methylated sites associated with rare genomic imprinting disorders.
A multistage GWAS suggests inherited SNPs at four sites in the genome can contribute to the risk of developing myeloproliferative neoplasms.
New micro-device is inexpensive to manufacture and can run nucleic acid amplification at room temperature.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.